CCR1 and Chagas disease: However, a Brazilian genetic polymorphism study of CCR1, CCR5, and their ligands CCL2 and CCL5, respectively, found CCL5-CCR1 to be the target for immune-stimulation from Trypanosoma cruzi infection.